These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 3432154)
21. Metabolism distribution and excretion of a matrix metalloproteinase-13 inhibitor, 4-[4-(4-fluorophenoxy)-benzenesulfonylamino]tetrahydropyran-4-carboxylic acid hydroxyamide (CP-544439), in rats and dogs: assessment of the metabolic profile of CP-544439 in plasma and urine of humans. Dalvie D; Cosker T; Boyden T; Zhou S; Schroeder C; Potchoiba MJ Drug Metab Dispos; 2008 Sep; 36(9):1869-83. PubMed ID: 18566038 [TBL] [Abstract][Full Text] [Related]
22. Metabolism of the neuroleptic agent zetidoline in the rat and the dog. Assandri A; Perazzi A; Fontanella L; Ferrari P; Ripamonti A; Tarzia G; Tuan G; Martinelli E Drug Metab Dispos; 1984; 12(5):635-40. PubMed ID: 6149917 [TBL] [Abstract][Full Text] [Related]
23. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees. Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025 [TBL] [Abstract][Full Text] [Related]
24. Metabolism of zimelidine in rat, dog and man. Identification and synthesis of the principal metabolites. Lundström J; Högberg T; Gosztonyi T; de Paulis T Arzneimittelforschung; 1981; 31(3):486-94. PubMed ID: 6452883 [TBL] [Abstract][Full Text] [Related]
25. [Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog]. Obermeier K; Niebch G; Thiemer K Arzneimittelforschung; 1985; 35(1):60-7. PubMed ID: 4039153 [TBL] [Abstract][Full Text] [Related]
26. N-acetylcyanamide, the major urinary metabolite of cyanamide in rat, rabbit, dog, and man. Shirota FN; Nagasawa HT; Kwon CH; DeMaster EG Drug Metab Dispos; 1984; 12(3):337-44. PubMed ID: 6145561 [TBL] [Abstract][Full Text] [Related]
27. Metabolic disposition of isoxicam in man, monkey, dog, and rat. Borondy PE; Michniewicz BM Drug Metab Dispos; 1984; 12(4):444-51. PubMed ID: 6148211 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the disposition and of the metabolic pattern of Reboxetine, a new antidepressant, in the rat, dog, monkey and man. Cocchiara G; Battaglia R; Pevarello P; Strolin Benedetti M Eur J Drug Metab Pharmacokinet; 1991; 16(3):231-9. PubMed ID: 1814741 [TBL] [Abstract][Full Text] [Related]
29. Comparative metabolism of tolbutamide by isolated hepatocytes from rat, rabbit, dog, and squirrel monkey. Gee SJ; Green CE; Tyson CA Drug Metab Dispos; 1984; 12(2):174-8. PubMed ID: 6144482 [TBL] [Abstract][Full Text] [Related]
30. Biotransformation of the antidepressant DL-rolipram. I. Isolation and identification of metabolites from rat, monkey, and human urine. Krause W; Kühne G; Jakobs U; Hoyer GA Drug Metab Dispos; 1993; 21(4):682-9. PubMed ID: 8104129 [TBL] [Abstract][Full Text] [Related]
31. Disposition of cefotaxime in rat, dog and man. Macdonald CM; Fromson JM; McDonald A; Dell D; Chamberlain J; Coombes JD Arzneimittelforschung; 1984; 34(12):1719-23. PubMed ID: 6099125 [TBL] [Abstract][Full Text] [Related]
32. The metabolic disposition of the selective beta 1-adrenoceptor agonist prenalterol in mice, rats, dogs, and humans. Hoffmann KJ; Arfwidsson A; Borg KO Drug Metab Dispos; 1982; 10(2):173-9. PubMed ID: 6124405 [TBL] [Abstract][Full Text] [Related]
33. Studies on the metabolism of tulobuterol . HCl. Identification of basic urinary metabolites in the dog, rat, rabbit, and guinea pig. Matsumura K; Kubo O; Sakashita T; Kato H; Watanabe K; Hirobe M Drug Metab Dispos; 1982; 10(5):537-41. PubMed ID: 6128206 [TBL] [Abstract][Full Text] [Related]
34. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor. Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513 [TBL] [Abstract][Full Text] [Related]
35. Comparison of amphetamine metabolism using isolated hepatocytes from five species including human. Green CE; LeValley SE; Tyson CA J Pharmacol Exp Ther; 1986 Jun; 237(3):931-6. PubMed ID: 3712286 [TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate. Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406 [TBL] [Abstract][Full Text] [Related]
37. Investigating the in vitro metabolism of fipexide: characterization of reactive metabolites using liquid chromatography/mass spectrometry. Sleno L; Staack RF; Varesio E; Hopfgartner G Rapid Commun Mass Spectrom; 2007; 21(14):2301-11. PubMed ID: 17577876 [TBL] [Abstract][Full Text] [Related]
38. The characterization of the metabolites of ranolazine in man by liquid chromatography mass spectrometry. Penman AD; Eadie J; Herron WJ; Reilly MA; Rush WR; Liu Y Rapid Commun Mass Spectrom; 1995; 9(14):1418-30. PubMed ID: 8534891 [TBL] [Abstract][Full Text] [Related]
39. Species differences in the metabolic conjugation of clofibric acid and clofibrate in laboratory animals and man. Emudianughe TS; Caldwell J; Sinclair KA; Smith RL Drug Metab Dispos; 1983; 11(2):97-102. PubMed ID: 6133730 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys. Okuyama Y; Morino A Arzneimittelforschung; 1997 Mar; 47(3):293-8. PubMed ID: 9105548 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]